Tanaka, Y., Yamanaka, H., Ishiguro, N., Miyasaka, N., Kawana, K., Kimura, J., . . . Takeuchi, T. (2017). Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study. Arthritis Res Ther.

Tanaka, Yoshiya, Hisashi Yamanaka, Naoki Ishiguro, Nobuyuki Miyasaka, Katsuyoshi Kawana, Junko Kimura, Naoki Agata, und Tsutomu Takeuchi. "Low Disease Activity for Up to 3 years After Adalimumab Discontinuation in Patients With Early Rheumatoid Arthritis: 2-year Results of the HOPEFUL-3 Study." Arthritis Res Ther 2017.

Tanaka, Yoshiya, et al. "Low Disease Activity for Up to 3 years After Adalimumab Discontinuation in Patients With Early Rheumatoid Arthritis: 2-year Results of the HOPEFUL-3 Study." Arthritis Res Ther 2017.